Nivolumab Adding on Gemcitabine/S-1 in Metastatic Pancreatic Cancer

NCT04377048 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Pancreatic Cancer

Interventions

DRUG: Nivolumab
DRUG: Gemcitabine
DRUG: Tegafur-Gimeracil-Oteracil

Sponsor

National Taiwan University Hospital

Collaborators

[object Object]
[object Object]
[object Object]